This webinar might be of interest to some
https://webinars.endpts.com/the-future-of-cell-therapy-manufacturing-has-arrived/?source=eblast
Thursday, September 21, 12:00 pm ET
.

The future of cell therapy manufacturing has arrived

Cell therapy development and approval rates have experienced unprecedented growth since the FDA approval of Kymriah in 2017. Today there are six approved cell therapies on the market. With more than 2,800 cell therapies in development, the pace of regulatory approvals is expected to increase dramatically.

While the recent pace of newly approved therapies is promising for patients, conventional CDMOs are unable to scale and meet total patient demand due to the lack of automated, high-throughput manufacturing technologies. Consequently, patients are dying while waiting for their life-saving treatments.

In this webinar, Fabian Gerlinghaus, CEO & Co-founder of Cellares, will unveil a new paradigm for mass manufacturing the personalized living drugs of the 21st century. Mr. Gerlinghaus will share how Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO), will overcome the limitations of conventional CDMOs and accelerate access to life-saving cell therapies for patients through:

• A global network of IDMO Smart Factories, which produce ten times more cell therapy batches using the same footprint and workforce as conventional CDMO facilities
• Reduction of manufacturing costs and process failure rates through closed and fully automated end-to-end manufacturing
• Integrated, high-throughput technologies for cell therapy manufacturing and in-process QC